COURSE PECULIARITIES OF NEUROCUTANEOUS MELANOSIS IN CHILDREN
https://doi.org/10.15690/vsp.v15i5.1626
Abstract
Neurocutaneous melanosis is part of a group of hereditary diseases characterized by large and/or multiple pigmented nevi, melanosis or melanoma of the pia mater, with no evidence of malignant skin lesions and involvement of other organs. The disease was described over 150 years ago, but its pathogenesis has not been studied yet, and treatment methods have not been developed yet. Different disease courses due to the pronounced polymorphism of clinical symptoms complicate the diagnosis, and the low efficacy of the symptomatic treatment worsens the disease prognosis. The article describes the experience of managing children with phakomatoses not similar to each other neither in debut and course nor in response to the therapy and prognosis. Early diagnosis of neurocutaneous melanosis in children allows to carry out timely symptomatic treatment and dynamical monitoring, and to improve the survival of patients.
About the Authors
Tatyana M. Prygunova
Nizhny Novgorod Regional Children's Clinical Hospital
Russian Federation
Russian Federation
Ekaterina I. Кarpovich
Nizhny Novgorod Regional Children's Clinical Hospital
Russian Federation
Russian Federation
Marina N. Chernigina
Nizhny Novgorod Regional Children's Clinical Hospital
Russian Federation
Russian Federation
Elena E. Beresneva
Nizhny Novgorod Regional Children's Clinical Hospital
Russian Federation
Russian Federation
Larisa A. Trynkova
Nizhny Novgorod Regional Children's Clinical Hospital
Russian Federation
Russian Federation
References
1. Заболевания нервной системы у детей / Под ред. Ж. Айкарди, М. Бакса и К. Гиллберга. Пер. с англ. / Под общ. ред. А.А. Скоромца. — М.: Изд-во Панфилова, БИНОМ, Лаборатория знаний, 2013. — Т. 1. — С. 105–139. [Aicardi J, Bax M, Gillberg C, editors. Diseases of the nervous system in childhood. Translated from English. Ed by A.A. Skoromts. Moscow: Izdatel’stvo Panfilova, BINOM, Laboratoriya znanii, 2013. Vol. 1. P. 105–139. (In Russ).]
2. Ruggieri M, Praticо AD. Mosaic neurocutaneous disorders and their causes. Semin Pediatr Neurol. 2015,22(4):207–233. doi: 10.1016/j.spen.2015.11.001.
3. Kumar M, Dhamija R. Teaching NeuroImages: neurocutaneous melanosis. Neurology. 2015,84(24):e207. doi: 10.1212/WNL.0000000000001689.
4. Gocmen R, Guler E, Arslan EA. A case of neurocutaneous mela-nosis and neuroimaging findings. J Radiol Case Rep. 2015,9(3):1–6. doi: 10.3941/jrcr.v9i3.2141.
5. Cho IY, Hwang SK, Kim SH. Dandy-walker malformation associated with neurocutaneous melanosis. J Korean Neurosurg Soc. 2011,50(5):475–477. doi: 10.3340/jkns.2011.50.5.475.
6. Burstein F, Seier H, Hudgins PA, Zapiach L. Neurocutaneous melanosis. J Craniofac Surg. 2005,16(5):874–876. doi: 10.1097/01.scs.0000181050.06696.4d.
7. Marnet D, Vinchon M, Mostofi K, et al. Neurocutaneous melanosis and the Dandy–Walker complex: an uncommon but not so insignificant association. Childs Nerv Syst. 2009,25(12):1533–1539. doi: 10.1007/s00381-009-0976-6.
8. Ginat DT, Meyers SP. Intracranial lesions with high signal intensity on T1-weighted MR images: differential diagnosis. Radiographics. 2012,32(2):499–516. doi: 10.1148/rg.322105761.
9. Alikhan A, Ibrahimi OA, Eisen DB. Congenital melanocytic nevi: where are we now? Part I. Clinical presentation, epidemiology, pathogenesis, histology, malignant transformation, and neuro cuta-neous melanosis. J Am Acad Dermatol. 2012,67(4):495.e1–495.e17. doi: 10.1016/j.jaad.2012.06.023.
10. Uguen A, Laurent C, Samaison L, et al. Severe hydrocephalus caused by diffuse leptomeningeal and neurocutaneous melanocytosis of antenatal onset: a clinical, pathologic, and molecular study of 2 cases. Hum Pathol. 2015,46(8):1189–1196. doi: 10.1016/j.humpath.2015.04.013.
11. Kusters-Vandevelde HV, Willemsen AE, Groenen PJ, et al. Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor. Acta Neuropathol Commun. 2014,2:41. doi: 10.1186/2051-5960-2-41.
12. Pavlidou E, Hagel C, Papavasilliou A, et al. Neurocutaneous melanosis: report of three cases and up-to-date review. J Child Neurol. 2008,23(12):1382–1391. doi: 10.1177/0883073808319069.
13. Makin GW, Eden OB, Lashford LS, et al. Leptomeningeal melanoma in childhood. Cancer. 1999,86(5):878–886. doi: 10.1002/(SICI)1097-0142(19990901)86:5<878::AID-CNCR26>3.0.CO,2-Y.
14. Ramaswamy V, Delaney H, Haque S, et al. Spectrum of central nervous system abnormalities in neurocutaneous melanocytosis. Dev Med Child Neurol. 2012,54(6):563–568. doi: 10.1111/j.1469-8749.2012.04275.x.
15. Kadonaga JN, Frieden IJ. Neurocutaneous melanosis: definition and review of the literature. J Am Acad Dermatol. 1991,24(5 Pt 1):747–755.
16. Viana AC, Gontijo B, Bittencourt FV. Giant congenital melanocytic nevus. An Bras Dermatol. 2013,88(6):863–878. doi: 10.1590/abd1806-4841.20132233.
17. Becher OJ, Souweidane M, Lavi E, et al. Large congenital melanotic nevi in an extremity with neurocutaneous melanocytosis. Pediatr Dermatol. 2009,26(1):79–82. doi: 10.1111/j.1525-1470.2008.00828.x.
18. Reyes-Mugica M, Chou P, Byrd S, et al. Nevomela no cytic prolifera- tions in the central nervous system of children. Cancer. 1993,72(7):2277–2285. doi: 10.1002/1097-0142(19931001)72:7<2277::AID-CNCR 2820720736>3.0.CO,2-F.
19. Yamazaki Y, Matsuzawa T, Takasugi K, et al. Rapidly progressive and fatal neurocutaneous melanosis presenting as recurrent headache. Pediatr Int. 2013,55(2):240–243. doi: 10.1111/j.1442-200X.2012.03653.x.
20. Banfalvi T, Gilde K, Gergye M, et al. Use of serum 5-S-CD and S-100B protein levels to monitor the clinical course of malignant melanoma. Eur J Cancer. 2003,39(2):164–169. doi: 10.1016/S0959-8049(02)00487-2.
Review
For citations:
Prygunova T.M., Кarpovich E.I., Chernigina M.N., Beresneva E.E., Trynkova L.A. COURSE PECULIARITIES OF NEUROCUTANEOUS MELANOSIS IN CHILDREN. Current Pediatrics. 2016;15(5):513-521. (In Russ.) https://doi.org/10.15690/vsp.v15i5.1626
Views:
3684
Email this article 
